Literature DB >> 21035500

Regulation and roles of PI3Kβ, a major actor in platelet signaling and functions.

Marie-Pierre Gratacap1, Julie Guillermet-Guibert, Valérie Martin, Gaëtan Chicanne, Hélène Tronchère, Frédérique Gaits-Iacovoni, Bernard Payrastre.   

Abstract

Phosphoinositide 3-kinases (PI3Ks) are important signaling enzymes involved in the regulation of a number of critical cell functions. Significant progress has been made during the last few years in defining the implication of individual PI3K isoforms. The role of the class IA PI3Kβ in different cell types has only been recently uncovered by the use of isoform-selective inhibitors and the development of mouse models harboring p110β catalytic subunit knock-out or germline knock-in of a kinase-dead allele of p110β. Although it is classically admitted that class IA PI3Ks are activated by receptor tyrosine kinases through recruitment of the regulatory subunits to specific tyrosine phosphorylated motifs via their SH2 domains, PI3Kβ is activated downstream of G protein-coupled receptors, and by co-operation between heterotrimeric G proteins and tyrosine kinases. PI3Kβ has been extensively studied in platelets where it appears to play an important role downstream of ITAM signaling, G protein-coupled receptors and aIIbβ3 integrin. Accordingly, mouse exhibiting p110β inactivation selectively in megakaryocyte/platelets are resistant to thromboembolism induced by carotid injury. The present review summarizes recent data concerning the mechanisms of PI3Kβ regulation and the roles of this PI3K isoform in blood platelet functions and other cell types.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21035500     DOI: 10.1016/j.advenzreg.2010.09.011

Source DB:  PubMed          Journal:  Adv Enzyme Regul        ISSN: 0065-2571


  23 in total

Review 1.  P2Y(12) receptors in platelets and other hematopoietic and non-hematopoietic cells.

Authors:  Christian Gachet
Journal:  Purinergic Signal       Date:  2012-04-11       Impact factor: 3.765

Review 2.  Therapeutic strategies for thrombosis: new targets and approaches.

Authors:  Nigel Mackman; Wolfgang Bergmeier; George A Stouffer; Jeffrey I Weitz
Journal:  Nat Rev Drug Discov       Date:  2020-03-04       Impact factor: 84.694

3.  Deubiquitinases Modulate Platelet Proteome Ubiquitination, Aggregation, and Thrombosis.

Authors:  Nilaksh Gupta; Wei Li; Thomas M McIntyre
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-10-15       Impact factor: 8.311

Review 4.  Current and future antiplatelet therapies: emphasis on preserving haemostasis.

Authors:  James D McFadyen; Mathieu Schaff; Karlheinz Peter
Journal:  Nat Rev Cardiol       Date:  2018-01-03       Impact factor: 32.419

5.  PI3King the right partner: unique interactions and signaling by p110β.

Authors:  Hashem A Dbouk
Journal:  Postdoc J       Date:  2015-06

6.  Rac1-stimulated macropinocytosis enhances Gβγ activation of PI3Kβ.

Authors:  Zahra Erami; Bassem D Khalil; Gilbert Salloum; Yanhua Yao; Jaclyn LoPiccolo; Aliaksei Shymanets; Bernd Nürnberg; Anne R Bresnick; Jonathan M Backer
Journal:  Biochem J       Date:  2017-11-16       Impact factor: 3.857

7.  P2 receptors and platelet function.

Authors:  Béatrice Hechler; Christian Gachet
Journal:  Purinergic Signal       Date:  2011-07-27       Impact factor: 3.765

8.  Phosphoinositide 3-Kinase Is Involved in Mediating the Anti-inflammation Effects of Vasopressin.

Authors:  Woan-Ching Jan; Ming-Chang Kao; Chen-Hsien Yang; Ya-Ying Chang; Chun-Jen Huang
Journal:  Inflammation       Date:  2017-04       Impact factor: 4.092

9.  A pharmacological model reveals biased dependency on PI3K isoforms for tumor cell growth.

Authors:  Xiang Wang; Jia-peng Li; Yan Yang; Jian Ding; Ling-hua Meng
Journal:  Acta Pharmacol Sin       Date:  2013-07-29       Impact factor: 6.150

Review 10.  Regulation of platelet plug formation by phosphoinositide metabolism.

Authors:  Sang H Min; Charles S Abrams
Journal:  Blood       Date:  2013-06-11       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.